Evidence map›Paper›PMID 42111962›Full record

ArticleOpen forum infectious diseases2026

Mpox Seroprevalence in General Population Groups in South Kivu, Democratic Republic of the Congo: A Comparative Description Before and During the Clade Ib Outbreak.

Antoine Nkuba-Ndaye, Neraide Biai, Adolphe Kwakanaba-Mweze, David Lupande-Mwenebitu, Tchass Chasinga-Buharanyi, Rodrigue Ayagirwe-Basengere, Noella Mukanya-Mulopo, Esperance Tsiwedi-Tsilabia, Marie-Anne Kavira-Muhindo, Benoît Mputu-Ngoyi and 12 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Antoine Nkuba-NdayeTransVIHMI, Université de Montpellier, Inserm, Institut de Recherche pour le Développement, Montpellier, France.ORCID https://orcid.org/0000-0003-2850-7498
Neraide BiaiTransVIHMI, Université de Montpellier, Inserm, Institut de Recherche pour le Développement, Montpellier, France.
Adolphe Kwakanaba-MwezeFaculté des Sciences Agronomiques et Environnement, Université Evangélique d'Afrique, Bukavu, Democratic Republic of the Congo.
David Lupande-MwenebituDépartement de Laboratoire, Centre des Maladies Tropicales et Santé Globale, Université Catholique de Bukavu, Sud-Kivu, Democratic Republic of the Congo.ORCID https://orcid.org/0000-0002-4124-1324
Tchass Chasinga-BuharanyiDépartement d'Anatomo-Pathologie, Hôpital Panzi, Bukavu, Democratic Republic of the Congo.
Rodrigue Ayagirwe-BasengereFaculté des Sciences Agronomiques et Environnement, Université Evangélique d'Afrique, Bukavu, Democratic Republic of the Congo.
Noella Mukanya-MulopoDépartement de Virolologie, Rodolphe Merieux Institut National de Recherche Biomédicale Goma, Goma, Democratic Republic of the Congo.
Esperance Tsiwedi-TsilabiaDépartement de Virolologie, Rodolphe Merieux Institut National de Recherche Biomédicale Goma, Goma, Democratic Republic of the Congo.
Marie-Anne Kavira-MuhindoDépartement de Virolologie, Rodolphe Merieux Institut National de Recherche Biomédicale Goma, Goma, Democratic Republic of the Congo.
Benoît Mputu-NgoyiDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Etienne Ndomba-MukanyaDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0000-0001-8887-7963
Jacques Kwizera-SendegeyaDépartement de Virolologie, Rodolphe Merieux Institut National de Recherche Biomédicale Goma, Goma, Democratic Republic of the Congo.
Louis GlénatTransVIHMI, Université de Montpellier, Inserm, Institut de Recherche pour le Développement, Montpellier, France.
Junior Bulabula-PengeDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0009-0009-4742-7419
Guillaume ThaurignacTransVIHMI, Université de Montpellier, Inserm, Institut de Recherche pour le Développement, Montpellier, France.
Daniel Mukadi-BamulekaDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0000-0002-6836-8704
Frédéric LeMarcisTransVIHMI, Université de Montpellier, Inserm, Institut de Recherche pour le Développement, Montpellier, France.ORCID https://orcid.org/0000-0001-8302-0864
Ahidjo AyoubaTransVIHMI, Université de Montpellier, Inserm, Institut de Recherche pour le Développement, Montpellier, France.ORCID https://orcid.org/0000-0002-5081-1632
Eric DelaporteTransVIHMI, Université de Montpellier, Inserm, Institut de Recherche pour le Développement, Montpellier, France.ORCID https://orcid.org/0000-0002-1822-9853
Martine PeetersTransVIHMI, Université de Montpellier, Inserm, Institut de Recherche pour le Développement, Montpellier, France.ORCID https://orcid.org/0000-0001-6738-8730
Almudena Mari-SaezTransVIHMI, Université de Montpellier, Inserm, Institut de Recherche pour le Développement, Montpellier, France.ORCID https://orcid.org/0000-0002-5429-8485
Steve Ahuka-MundekeDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0009-0009-5210-864X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to assess mpox virus (MPXV) seroprevalence in South Kivu, Democratic Republic of the Congo, where a large mpox outbreak started at the end of 2023. A community-based surveys was conducted in urban (April-May 2023) and rural (July-August 2024) areas and a multiplex serological assay to detect anti-IgG against MPXV has been used. MPXV seroprevalence was 3.3% in the urban survey (n = 1174) and 8.3% in the rural survey (n = 981), with differences according to health zone (

Indexed as

Democratic Republic of CongompoxseroprevalenceSouth Kivu

Identifiers

PMID42111962
PMCPMC13152093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.